A Single Nucleotide Polymorphism within the Acetyl-Coenzyme A Carboxylase Beta Gene Is Associated with Proteinuria in Patients with Type 2 Diabetes
It has been suggested that genetic susceptibility plays an important role in the pathogenesis of diabetic nephropathy. A large-scale genotyping analysis of gene-based single nucleotide polymorphisms (SNPs) in Japanese patients with type 2 diabetes identified the gene encoding acetyl-coenzyme A carboxylase beta (ACACB) as a candidate for a susceptibility to diabetic nephropathy; the landmark SNP was found in the intron 18 of ACACB (rs2268388: intron 18 +4139 C > T, p = 1.4×10−6, odds ratio = 1.61, 95% confidence interval [CI]: 1.33–1.96). The association of this SNP with diabetic nephropathy was examined in 9 independent studies (4 from Japan including the original study, one Singaporean, one Korean, and two European) with type 2 diabetes. One case-control study involving European patients with type 1 diabetes was included. The frequency of the T allele for SNP rs2268388 was consistently higher among patients with type 2 diabetes and proteinuria. A meta-analysis revealed that rs2268388 was significantly associated with proteinuria in Japanese patients with type 2 diabetes (p = 5.35×10−8, odds ratio = 1.61, 95% Cl: 1.35–1.91). Rs2268388 was also associated with type 2 diabetes–associated end-stage renal disease (ESRD) in European Americans (p = 6×10−4, odds ratio = 1.61, 95% Cl: 1.22–2.13). Significant association was not detected between this SNP and nephropathy in those with type 1 diabetes. A subsequent in vitro functional analysis revealed that a 29-bp DNA fragment, including rs2268388, had significant enhancer activity in cultured human renal proximal tubular epithelial cells. Fragments corresponding to the disease susceptibility allele (T) had higher enhancer activity than those of the major allele. These results suggest that ACACB is a strong candidate for conferring susceptibility for proteinuria in patients with type 2 diabetes.
Vyšlo v časopise:
A Single Nucleotide Polymorphism within the Acetyl-Coenzyme A Carboxylase Beta Gene Is Associated with Proteinuria in Patients with Type 2 Diabetes. PLoS Genet 6(2): e32767. doi:10.1371/journal.pgen.1000842
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1000842
Souhrn
It has been suggested that genetic susceptibility plays an important role in the pathogenesis of diabetic nephropathy. A large-scale genotyping analysis of gene-based single nucleotide polymorphisms (SNPs) in Japanese patients with type 2 diabetes identified the gene encoding acetyl-coenzyme A carboxylase beta (ACACB) as a candidate for a susceptibility to diabetic nephropathy; the landmark SNP was found in the intron 18 of ACACB (rs2268388: intron 18 +4139 C > T, p = 1.4×10−6, odds ratio = 1.61, 95% confidence interval [CI]: 1.33–1.96). The association of this SNP with diabetic nephropathy was examined in 9 independent studies (4 from Japan including the original study, one Singaporean, one Korean, and two European) with type 2 diabetes. One case-control study involving European patients with type 1 diabetes was included. The frequency of the T allele for SNP rs2268388 was consistently higher among patients with type 2 diabetes and proteinuria. A meta-analysis revealed that rs2268388 was significantly associated with proteinuria in Japanese patients with type 2 diabetes (p = 5.35×10−8, odds ratio = 1.61, 95% Cl: 1.35–1.91). Rs2268388 was also associated with type 2 diabetes–associated end-stage renal disease (ESRD) in European Americans (p = 6×10−4, odds ratio = 1.61, 95% Cl: 1.22–2.13). Significant association was not detected between this SNP and nephropathy in those with type 1 diabetes. A subsequent in vitro functional analysis revealed that a 29-bp DNA fragment, including rs2268388, had significant enhancer activity in cultured human renal proximal tubular epithelial cells. Fragments corresponding to the disease susceptibility allele (T) had higher enhancer activity than those of the major allele. These results suggest that ACACB is a strong candidate for conferring susceptibility for proteinuria in patients with type 2 diabetes.
Zdroje
1. U S Renal Data System 2008 USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
2. NakaiS
MasakaneI
AkibaT
ShigematsuT
YamagataK
2008 Overview of Regular Dialysis Treatment in Japan as of 31 December 2006. Ther Apher Dial 12 428 456
3. SeaquistER
GoetzFC
RichS
BarbosaJ
1989 Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320 1161 1165
4. QuinnM
AngelicoMC
WarramJH
KrolewskiAS
1996 Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39 940 945
5. FreedmanBI
BostromM
DaeihaghP
BowdenDW
2007 Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol 2 1306 1316
6. MaedaS
2008 Genetics of diabetic nephropathy Ther Adv Cardiovasc Dis 2 363 371
7. FraylingTM
2007 Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8 657 662
8. ProkopenkoI
McCarthyMI
LindgrenCM
2008 Type 2 diabetes: new genes, new understanding. Trends Genet 24 613 621
9. UnokiH
TakahashiA
KawaguchiT
HaraK
HorikoshiM
2008 SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet 40 1098 1102
10. YasudaK
MiyakeK
HorikawaY
HaraK
OsawaH
2008 Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 40 1092 1097
11. PezzolesiMG
PoznikGD
MychaleckyjJC
PatersonAD
BaratiMT
2009 Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 58 1403 1410
12. HagaH
YamadaR
OhnishiY
NakamuraY
TanakaT
2002 Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. Single-nucleotide polymorphism. J Hum Genet 47 605 610
13. HirakawaM
TanakaT
HashimotoY
KurodaM
TakagiT
2002 JSNP: a database of common gene variations in the Japanese population. Nucleic Acids Res 30 158 162
14. TanakaN
BabazonoT
SaitoS
SekineA
TsunodaT
2003 Association of solute carrier family 12 (sodium/chloride) member 3 with diabetic nephropathy, identified by genome-wide analyses of single nucleotide polymorphisms. Diabetes 52 2848 2853
15. ShimazakiA
KawamuraY
KanazawaA
SekineA
SaitoS
2005 Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes 54 1171 1178
16. KamiyamaM
KobayashiM
ArakiS
IidaA
TsunodaT
2007 Polymorphisms in the 3′ UTR in the neurocalcin δ gene affect mRNA stability, and confer susceptibility to diabetic nephropathy. Hum Genet 122 397 407
17. LeakTS
PerlegasPS
SmithSG
KeeneKL
HicksPJ
2009 Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans. Ann Hum Genet 73 152 159
18. PezzolesiMG
KatavetinP
KureM
PoznikGD
SkupienJ
2009 Confirmation of Genetic Associations at ELMO1 in the GoKinD Collection Support its Role as a Susceptibility Gene in Diabetic Nephropathy. Diabetes 58 2698 2702
19. Abu-ElheigaL
MatzukMM
Abo-HashemaKA
WakilSJ
2001 Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291 2613 2616
20. Abu-ElheigaL
OhW
KordariP
WakilSJ
2003 Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc Natl Acad Sci U S A 100 10207 10212
21. OhW
Abu-ElheigaL
KordariP
GuZ
ShaikenovT
2005 Glucose and fat metabolism in adipose tissue of acetyl-CoA carboxylase 2 knockout mice. Proc Natl Acad Sci U S A 102 1384 1389
22. Abu-ElheigaL
Almarza-OrtegaDB
BaldiniA
WakilSJ
1997 Human acetyl-CoA carboxylase 2. Molecular cloning, characterization, chromosomal mapping, and evidence for two isoforms. J Biol Chem 272 10669 10677
23. KumeS
UzuT
IsshikiK
KoyaD
2008 Peroxisome proliferator-activated receptors in diabetic nephropathy. PPAR Res 2008 879523
24. WahbaIM
MakRH
2007 Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2 550 562
25. KrolewskiAS
PoznikGD
PlachaG
CananiL
DunnJ
2006 A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int 69 129 136
26. ArakiS
HanedaM
SugimotoT
IsonoM
IsshikiK
2005 Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes 54 2983 2987
27. NishiyamaK
TanakaY
NakajimaK
MokuboA
AtsumiY
2005 Polymorphism of the solute carrier family 12 (sodium/chloride transporters) member 3, SLC12A3, gene at exon 23 (+78G/A: Arg913Gln) is associated with elevation of urinary albumin excretion in Japanese patients with type 2 diabetes: a 10-year longitudinal study. Diabetologia 48 1335 1338
28. KimJH
ShinHD
ParkBL
MoonMK
ChoYM
2006 SLC12A3 (solute carrier family 12 member [sodium/chloride] 3) polymorphisms are associated with end-stage renal disease in diabetic nephropathy. Diabetes 55 843 848
29. NgDPK
FukushimaM
TaiBC
KohD
LeongH
2008 Reduced glomerular filtration rate and albuminuria in type 2 diabetes mellitus are both independently associated with activation of the TNF-alpha system. Diabetologia 51 2318 2324
30. GaedeP
VedelP
LarsenN
JensenGV
ParvingHH
2003 Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348 383 393
31. JorsalA
TarnowL
FrystykJ
LajerM
FlyvbjergA
2008 Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int 74 649 654
32. NielsenDM
EhmMG
WeirBS
1998 Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am J Hum Genet 63 1531 1540
33. DevlinB
RischN
1995 A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29 311 322
34. SladekR
RocheleauG
RungJ
DinaC
ShenL
2007 A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 881 885
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2010 Číslo 2
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Genome-Wide Association Study in Asian Populations Identifies Variants in and Associated with Systemic Lupus Erythematosus
- Nuclear Pore Proteins Nup153 and Megator Define Transcriptionally Active Regions in the Genome
- The Genetic Interpretation of Area under the ROC Curve in Genomic Profiling
- Nucleoporins and Transcription: New Connections, New Questions